Trials / Completed
CompletedNCT00595309
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 on Long Term Immunogenicity. An Uncontrolled, Open-label Phase 3 Study.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- Valneva Austria GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective is to assess the effect of a booster vaccination on immunogenicity of IC51 in terms of seroconversion rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IC51 | IC51, 6 mcg, intramuscular (i.m.) booster vaccination 15 months after the primary immunization |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-01-16
- Last updated
- 2014-05-16
- Results posted
- 2012-06-27
Locations
3 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT00595309. Inclusion in this directory is not an endorsement.